Date: August 23 and 24, 2024
Format: In person
Local: Faculdade Sírio-Libanês – Campus Bela Vista | Rua Professor Daher Cutait, 69 - Bela Vista – São Paulo/SP
Coordination:
• Dra. Maria Cristina Seiwald
• Dra. Yana Novis
Presentation:
TThe International Conference on Updates in Onco-Hematology and Cell Therapy aims to bring the latest in these areas, which have seen great scientific progress in recent years. It aims to promote the exposition and debate of themes, in addition to encouraging interaction between participants and speakers.
The event will address the latest and most relevant advances in these fields, issues that directly impact the day-to-day clinical care, presenting and discussing them with a critical view on the subject.
Target Audience:
• Physicians specializing in hematology, onco-hematology and bone marrow transplantation
Goals:
• Update in Hematology, focusing on onco-hematology
• Bone marrow transplant
• Cell therapy
Differentials:
• International Speakers
• Interactive classes
Maria Cristina N. Seiwald, MD
Yana Novis, MD
Andrew Davies
.svg){kind=icon}
Courtney Dinardo
Olalekan Oluwole
.svg)
Javier Pinilla
Ola Landgren
Dr. Alfredo Mendrone Jr
Dra. Aliana Meneses
Dra. Amanda Udo
Dra. Ana Rita Fonseca
Dr. Andre Domingues Pereira
Dra. Andreza Ribeiro
Dra. Anita Cortez
Dra. Belinda Simões
Dr. Carlos Chiattone
Dra. Cyntia Arrais
Dr. Erick Menezes Xavier
Dr. Fábio Pires
Dr. Fernando Pericole
Dr. Guilherme Duffles
Dr. Guilherme Fonseca
Dr. Guilherme Perini
Dra. Luciana Tucunduva
Dra. Lucila Kerbauy
Dra. Mariana Gomes Serpa
Dra. Martha Mariana de Almeida Santos Arruda
Dr. Vanderson Rocha
Dra. Virgínia Picanço
Dr. Volney Assis Lara Vilela
| Schedule: Friday, August 23th 2024
*Programming subject to changes and guest confirmations |
|
 Live participation online |
|
 Recorded video participation |
|
| 12:00 – 12:50 | In-person Accreditation: Faculdade Sírio-Libanês, Campus Bela Vista [Rua Professor Daher Cutait, 69 – Bela Vista – São Paulo/SP] |
| 12:50 – 13:00 | Opening |
|
Module 1: Cellular Therapy (CPC) Chair: Dra. Cyntia Arrais e Dr. Vanderson Rocha |
|
| 13:00 – 13:20 |
Cryopreservation of hematopoietic progenitor cells (HPC) Dr. Alfredo Mendrone Jr |
| 13:20 – 13:40 |
CAR-NK anti CD19 Dra. Virginia Picanço |
| 13:40 – 14:00 |
Question and Answer Session Dra. Cyntia Arrais, Dr. Alfredo Mendrone Jr., Dra. Virginia Picanço e Dr. Vanderson Rocha |
|
Module 2: CAR – T vs TMO Debate Chairs: Dra. Ana Rita Fonseca e Dra. Lucila Kerbauy |
|
14:00 – 14:20  |
CAR-T in second line in diffuse large cell lymphoma Dr. Olalekan O. Oluwole (Vanderbilt University Medical Center - Nashville) |
14:20 – 14:40  |
Second-line autologous BMT in diffuse large cell lymphoma Dr. Andrew Davies (Southampton University) |
| 14:40 – 15:00 |
Question and Answer Session Dra. Ana Rita Fonseca, Dra. Lucila Kerbauy, Dr. Olalekan O. Oluwole e Dr. Andrew Davies |
| 15:00 – 15:40 |
Satellite Symposium - Kite/Gilead The Impact of CAR-T on the 2L B-Cell Lymphoma Patient Journey Dr. Vanderson Rocha |
| 15:40 - 16:10 | Break |
|
Module 3: CAR-T vs Bispecifics Debate Chairs: Dr. Erick Xavier e Dra. Yana Novis |
|
| 16:10 – 16:30 |
CAR-T for lymphoma Dr. Olalekan O. Oluwole (Vanderbilt University Medical Center - Nashville) |
| 16:30 – 16:50 |
Bispecifics in Diffuse Large B-Cell Lymphoma Dr. Andrew Davies (Southampton University) |
| 16:50 - 17:10 |
Question and Answer Session Dr. Erick Xavier, Dra. Yana Novis, Dr. Andrew Davies e Dr. Olalekan O. Oluwole |
| 17:10 - 17:50 |
Satellite Symposium – Janssen Scientific Updates on the Treatment of Eligible MM 1L Dra. Mariana Serpa |
|
Module 4: Multiple Myeloma Chairs: Dra. Mariana Serpa e Dra. Anita Cortez |
|
| 17:50 - 18:10 |
MRD-guided therapy in multiple myeloma: are we ready? Dr. Ola Landgren (University of Miami)
|
| 18:10 – 18:30 |
Mieloma Múltiplo – Biespecifico antes de CAR-T? Dr. Fernando Pericole |
| 18:30 – 18:50 |
Multiple Myeloma – CAR-T before Bispecifics Dr. Ola Landgren (University of Miami)
|
| 18:50 – 19:10 |
Question and Answer Session Dra. Mariana Serpa, Dra. Anita Cortez, Dr. Ola Landgren e Dr. Fernando Pericole |
| 19:10 – 20:00 | Welcome cocktail |
| Schedule: Saturday, August 24th 2024
*Programming subject to changes and guest confirmations |
|
| 08:00 – 09:00 |
Meet The Professor – Abbvie (Diffuse Large Cell Lymphoma)* Dr. Paulo Henrique Soares Meet The Professor– Novartis (CAR-T)* Dra. Lucila Kerbauy Meet The Professor – Amgem (LLA)* Dr. Fábio Pires *Limited to 30 spots - registrations soon |
|
Module 5: LMA/SMD Chairs: Dra. Maria Cristina N. Seiwald e Dr. Guilherme Fonseca |
|
| 09:00 - 09:20 |
First-line therapy for high-risk MDS Dr. Fabio Pires (BP) |
| 09:20 – 09:40 |
LMA: beyond D3A7 Dra. Courtney DiNardo (MD – Anderson) |
| 09:40 – 10:00 |
Treatment Options for Patients With Relapsed, Refractory, or Persistent AML Dra Courtney DiNardo |
| 10:00 - 10:20 |
Question and Answer Session Dra. Maria Cristina N. Seiwald, Dr. Guilherme Fonseca, Dr. Fabio Pires (BP) e Dra. Courtney DiNardo (MD – Anderson) |
| 10:20 – 10:50 | Break |
|
Module 6: Difficult Clinical Cases Session – Lymphomas Chairs: Dr. Volney Vilela e Dra. Aliana Meneses |
|
| 10:50 – 11:15 |
Follicular lymphoma: relapse Dr. Andrew Davies (Southampton University) |
| 11:15 – 11:40 |
Mantle Lymphoma: 1st line therapy Dr. Guilherme Duffles |
| 11:40 – 12:00 |
Question and Answer Session Dr. Volney Vilela e Dra. Aliana Meneses, Dr. Andrew Davies e Dr. Guilherme Duffles |
| 12:00 – 12:40 |
Satellite Symposium – Lilly Non-covalent iBTK in LCM Dr. Diego Villa Clé |
| 12:40 – 13:40 |
Lunch break Meet the Professor – Roche (Updates on the treatment of Diffuse Large Cells B Lymphoma)* Dr. Andrew Davies e Dr. Erik Xavier Meet the Professor – Abbvie (LMA)* Dra. Maria Cristina Seiwald e Dra. Mariana Serpa *Limited spots available |
|
Module 7: LLC Debate Chair: Dr. Andre Domingues e Dr. Carlos Chiattone |
|
| 13:40 – 14:05 |
Finite first-line therapy in CLL Dr. Javier Pinilla |
| 14:05 – 14:30 |
Therapy remains first line in CLL Dr Guilheme Perini |
| 14:30 – 14:50 |
Question and Answer Session Dr. André Domingues, Dr. Guilherme Perini e Dr. Javier Pinilla |
| 14:50 – 15:30 |
AstraZeneca Satellite Symposium The role of therapy continues for the high-risk CLL patient Dr. Javier Pinilla |
|
Module 8: LLA Chairs: Dra. Martha Mariana Arruda, Dra. Andreza Ribeiro e Dra. Amanda Udo |
|
| 15:30 – 15:50 |
Immunotherapy in ALL Dra. Belinda Simões |
| 15:50 – 16:10 |
CAR-T in ALL – Bridge or definitive therapy? Dra Luciana Tucunduva |
| 16:10 – 16:30 |
Question and Answer Session Dra. Martha Mariana Arruda, Dra. Andreza Ribeiro, Dra. Luciana Tucunduva, Dra. Belinda Simões e Dra. Amanda Udo |
| 16:30 | Closure |
